With the current price of $1.19, the stock of Castlight Health, Inc. (NYSE:CSLT) concluded the trading session seeing its price drop by -0.1 points or at a loss of -7.75% compared to its previous day’s closing price of $1.29. About 1.518 million shares of the stock changed hands on the day. The trading volume of CSLT’s shares during the past session compares with the stock’s average daily trading volume of 1.449 million shares. On the other hand, a float of 72.99 million shares and a weekly performance of 8.18% make the stock worth to keep an eye on. Analysts are in agreement on an annual target price of $1.31 for CSLT’s share which suggests that the stock, price of which is currently buoying between $1.16 and $1.3, has a potential to gain 10.08%.
The latest data released on July 31, 2020 shows that the short float in the Castlight Health, Inc.’s stock is trending downward as short interest in CSLT shares turned down leaving more number of shares available to public for trading. Number of shares shorted in the CSLT is currently comprised of 2.75% of the float. Over the past two weeks, stock’s short interests weakened as number of shorted shares increased to shares from the previous figure of shares. Stock’s average intraday volume is now standing at shares which indicate that the days to cover the shorts are nearly.
After concluding the day’s trading, price of Castlight Health, Inc. (NYSE:CSLT) is up $0.09 over the week and it is $0.376 above 20-day average price. The highest price touched by the stock on the day was lower than 52-week high price of $1.79 that was attained on 10/25/19.
The stock has traded as low as $0.6 in past 52-week, and its current price is 98.33% above from that 52-week low price mark recorded on 03/09/20, which is an indicator that could increase the investors’ motivation level in taking advantage of price surge the stock has currently been going through. Stock currently has its beta at 1.62. A beta value of more than 1 represents higher volatility of a stock than that of the market and for the reason investors closely watch the behavior of such stock.
Current indicators are pointing at 60.22 as 14-days RSI of Castlight Health, Inc. This means that the CSLT is currently in a neutral territory and its share’s price movement is likely to be steady for a while. Similarly, the stochastic oscillator is indicating a momentum of 58.09%, implying stock’s share price is buoying in a neutral state.
Technical chart is showing 1st resistance point of $1.2733 for the CSLT’s share while placing it at a 2nd resistance point of $1.3567 to be settled at. But if the stock takes a plunge lower than the 1st support price of $1.1333 then its market would become weakened. And that would likely sliding the stock price down to 2nd support price level of $1.0767.
MACD oscillator is showing a reading of 0.0511 for the stock which means that it is currently in the green zone. Any movement above or below the zero level of the indicator has always being noticed by the investors as it makes them compare the stock’s average measure in short-term with that in the long-term. An MACD evaluation of more than zero means that stock has a stronger short-term average than long-term average, which implies that stock’s price is likely to climb up. But an MACD below zero indicates weaker short-term average compare to the long-term average.
Wells Fargo lowered its recommendation for CSLT stock from Equal Weight to Underweight in a review note dated January 08. The stock gets its recommendation downgraded from Buy to Hold from the analysts at Canaccord Genuity who assigned a target price of $4 to $1.50 in their November 20 note to investors.Cantor Fitzgeraldanalysts downgraded their recommendation from Overweight to Neutral on July 31.
The average rating of 2.5 for CSLT is placing the stock in bullish category at the moment. In a poll by Reuters including 6 analysts in it who kept tracking the Castlight Health, Inc., 3 rated the stock as hold. Others were in different opinions for the CSLT. Out of remaining 3 analysts, 2 rated the stock as a buy or strong buy. 1 were in favor of a sell rating for the stock while advising investors to shun the stock if they already have any or otherwise not to buy it.
A quick look at other side of the picture shows that CSLT stock is lagging behind earnings per share estimates with a forward price-to-earnings ratio of 0.
Projection by Zacks Consensus Estimates suggests that Castlight Health, Inc. (NYSE:CSLT) will see its current-quarter revenues drop by nearly -99.92% to be decreased to about $30.12 million. Full-year revenue of the company is however forecasted to be fell to nearly -7.04% to bring $133.22 million in revenues against last year revenue of $143.31 million. Earnings, after adjustments, are likely to surge by 0% to post an EPS of -$0.04, while estimate for company’s full year earnings is -$0.1 per share with a growth rate of -28.57%.